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1. Introduction 
General information about platelets, origin of plateletes and granule contents of platelets 
were summarized. 
2. Platelets 
These cell fragments are morphologically small scale but functionally vital under life 
threatening conditions (1). They originate from megakaryocytes located mainly in the bone 
marrow, found in circulating blood and stored in spleen (2). Platelets don’t contain a nuclei 
and during their inactive state they have a discoid morphology with a diameter of 2-4 
micrometer (3, 4). But whenever they are active they can change their morphology very 
rapidly to an irregular branched spread form (5). Currently platelets are being used at wide 
spread clinic treatments from cosmetic needs to supporting insufficient heart (6, 7). 
2.1. Development of Platelets 
It is not exactly explained how platelets originate from megakaryocytes. There are several 
models to explain formation of platelets.  
Megakaryocytes seem to locate as triple form. With their VEGF secretion capacity they hold 
vessel endothelial cells close to themselves (8). The most scientifically accepted three models 
are mentioned as,  
1. Simply blebbing from the cell membrane of megakaryocytes (1).  
2. In megakaryocytes there are special cell fields defined as “Demarcation Membrane 
System” where granules of platelets condense and fragments break away (9). 
3. The most popular theory seems to be “Proplatelet Formation”. Here megakaryocytes 
have long thin branch like extensions at the blood circulating site of blood vessels of 
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bone marrow and on these branches there are uprising small bodies where by the help 
of blood shear force platelets enter directly to circulating blood stream. It was suggested 
that the concept of platelet like bodies arise from pseudopods of Megakaryocytes, the 
forming platelets were named as “proplatelet” (10). 
 
 
 
 
Figure 1. Megakaryocyte branches with Platelet Buds (PB) are seen. Proplatelets are released as 
Dumbell shaped bodies. This image is referenced from Hartwig and Italiano 2003 (Thanks for the 
kind permission of John Wiley and Sons to use this image) (11) .  
Kinetics of platelets; they have a life span as 7-10 days and in 1 liter human blood it is 
estimated that there are 150-400X109 platelets so for a balanced number they are formed 
15X109 -40X109 daily. Megakaryocytes located in the bone marrow sinusoids form a barrier 
to other bone marrow cells, it forms a physical barrier preventing direct contact to blood 
circulation. But there are canallicular openings in megakaryocyte membrane which permits 
cell migration to other cells to enter blood stream; this is named as “Emperipolesis” (8). 
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These small cell fragments have complex properties; 2 cytoplasmic regions can be seen in 
platelets  
1. Hyalomere: The light blue homogeneous region of the peripheral cytoplasm is called 
Hyalomere. Hyalomere includes cytoplasmic filaments and circumferential microtubule 
bundle under the cell membrane. These elements of the cytoskeleton provide the 
movement and the protection of the platelets’ shapes. 
2. Granulomere (Chromomere): This is the central region and tight area. It is ranging in 
color from blue to purple-staining. Granulomere includes small Golgi complex, smooth 
endoplasmic reticulum, lysosome, scattered granules surrounded by a membrane and a 
variety of mitochondria (4).  
Platelets have a simple appearance but carry very complex functional properties. By 
dividing this simple cell fragment to four regions helps for a better understanding of the 
functions of platelets. 
1. Peripheral Zone: 
This region is composed from unit membrane with open canalicular system. Three parts 
are defined as; 
a. Exterior outer layer:  
This is a glycocalix membrane with 10-20 nm thickness and thicker than the other blood 
cells, rich from glycoproteins that are mainly receptors for cell-cell and cell-vessel 
interactions(1, 8). 
b. Platelet Unit Membrane: 
Platelet unit membrane has some similarities and appearance with other unit 
membranes of cells, it is composed from bilipid layer rich of phospholipids (12), it can 
distribute molecules according to phsico-chemical properties for passing the membrane. 
The membrane has anionic and cationic pumps. Platelet unit membrane is an important 
catalyst for liquid phase coagulation. 
c. Submembrane Zone: 
Just located under the unit membrane a layer composed of microflament network. This 
network is anatomically and functionally related to membrane glycoproteins and 
cytoplasmic filament system. 
2. Sol-Jel Zone:  
This is cytoplasm corresponding part of the cellular fragment, platelet. It is in soluble or 
gel phase according to changes of polymerization of the filaments; actin and 
microtubules(1).  
Just under the submembrane zone there are microtubules forming a peripheral ring 
which helps platelet to maintain its discoid shape in inactive form. When activated, 
the microtubules surround the organelles and with the contribution of other filaments 
(13), the organelles are tightly contracted. During silent form only 30-40 % of actin 
filaments are polymerized, when platelets are activated the polymerized amount 
increases(1). 
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3. Organel Zone: 
This is the zone where granule’s, peroxisome’s, lysosome’s and mitochondria’s are 
localized. There are enzymes, adenine nucleotids, calcium, serotonin and many other 
proteins in this region (1). 
4. Membrane Zone 
There is a distinguishing feature of platelets that their plasma membrane contains wide 
spread invaginations that forms a network inside platelet. Finally with pore openings 
the inner network is directly in contact with outer zone. This system is named as “open 
canallicular system” (OCS) and with this system an extensive amount of surface area 
stays as potential in silent state. With this system also platelet gains a large area for 
molecular trafficking. A second canal system is composed from endoplasmic reticulum 
networks and named as “Dense Tubular System” (DTS). Here in DTS many enzymes 
and calcium ions that are important for activation are located. DTS is not directly 
connected to outer membrane (1, 14) but has close connections with OCS. These two 
systems actively exchange molecules (1). 
The granulles have diameters ranging between 200 to 500 nm and they are found as 
spherical or oval structures (15). There are 3 types of granules in platelets, Alfa 
Granules, Dense granules, lysosomes. Alpha granules are most prominent in terms of 
material content and majority. These granules include inflammatory molecules, 
cytokines, cell-activating molecules, proteins, Growth Factors, adhesion molecules, 
integrins and other proteins These granules are filled by megakaryocytes (3). 
3. Alpha granules 
It is widely accepted that these granules come from the budding of trans golgi apparatus 
organel of megakaryocytes (16, 17). 
These are 200-400 nm diameter granules widespread in the cytoplasm (16) which gives the 
granular appearance in Romanoski stained smear preparations, each platelet contains 
around 50-80 of these granules. The content of granules is very diverse; a brief list is given in 
table 1 (14, 18, 19, 20, 21). 
When platelets are activated these alpha granules fuse with each other, OCS and plasma 
membrane. The secretion of alpha granules is mediated by some proteins (such as SNARE) 
and membrane lipids (19).  
The secretions effect platelet and cells in the environment (such as endothelial, leukocytes) 
for migration, adhesion and proliferation(14). 
A rare syndrome named as Gray Thrombocyte Syndrome (GTS) is both involved with the 
quantity and quality of platelets which cases susceptibility for bleeding. In GTS the proteins 
synthesized by megakaryocytes are abnormal and don’t enter platelets as they do in normal 
individuals and additionally the endocytotic mechanisms don’t work properly. As a result 
the secretions spread to bone marrow and a fibrosis forms (miyelofibrozis)(22, 23). 
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Thrombospondin 
 P-selectin 
 platelet factor 4  
 beta thromboglobulinler 
Factors  V, XI, XIII  fibrinogen 
 von Willebrand factor 
fibronectin 
 vitronectin  
high molecular weight complexes kininogen  
chemokines 
 mitogenic growth factors (platelet-derived growth factor) 
 vascular endothelial growth factor  
TGF-beta 
Table 1. Some main components of alpha granules.  
4. Dense granules 
These are smaller granules with 150 nm diameter (24), because of the calcium and 
phosphate content there image seems dense under electron microscopic (EM) observation 
(21, 25). Each platelet contains 3-8 of these granules (14). The components of dense granules 
are briefly given in Table 2 (10, 14, 19, 20).  
 
Ca 
 Mg 
 P 
 pyrophosphate Nucleotides ATP, GTP, ADP, GDP 
 Membrane proteins 
 CD63 (granulophysin) 
 LAMP 2 
 Serotonin 
 GPIb, GPIIb/IIIa 
 P-Selectin 
Histamine 
 Epinephrine 
Table 2. Some main components of dense granules. 
In activated platelet these granules fuse with plasma membrane and expel their ingredients 
to their environment which causes other platelets to aggregate and a local vasoconstriction 
(especially by serotonin) in the involved vessels. Also the ADP content is a very important 
participant for homeostasis (14). 
The importance of the components of dense granules for homeostasis is recognized when 
the diseases of the deficiency of dense granules was defined as Hermansky-Pudlak 
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Syndrome (26, 27, 28) and Chediak Higashi Syndrome.  In both syndromes stoppage of 
bleeding is defective based on the impairment in dense granules (14). 
5. Lysosomes 
They have a diameter of 200-250 nm which places them to middle size granule (14). They 
can’t be distinguished from alpha granules under EM observation because of the similarities 
in dense electron appearance. By the content of acid phosphates and arylsulphates 
cytochemical staining techniques can effectively distinguish lysosomes from alpha granules. 
In an activated platelet they expel their contents to environment as the other two granules 
by membrane fusing mechanisms. The difference for lysosomes to be involved in activation 
is that they need a more potent stimulus. The role of lysosomal components in homeostasis 
is not well understood as the other granules contribution. They are involved in thrombus 
formation and extracellular matrix remodeling (8).  
It seems that lysosomes in platelets don’t have any distinguished features, they share the 
common features with other cells lysosomes (29). 
The components of dense granules are briefly given in Table 3 (8, 18, 30, 31, 32). 
 
Figure 2. M: Mitochondria, αG: alfa-granules, DG: dense granules, Gly: glycogen particles and OCS: 
open canalicular system. The morphology can be seen in equatorial section of a human platelet. This 
image is referenced from Zufferey 2011 (Thanks for the kind permission of John Wiley and Sons to use 
this image)(33). 
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PF3  
Acid phosphatase  
Glucose-6 phosphatase  
Arabinosidase  
N-Acetyl-galactosominidase 
 ATP = adenosine triphosphate 
 TGF 
 CD63 
 Cathepsin 
 lysosomal membrane proteins (LAMP-1, LAMP-2) 
acid hydrolases 
 cathepsins 
 
Table 3. Some main components of platelet lysosomes  
6. Autologous platelet rich plasma (PRP) 
The application of growth factors in medical practice is one of the areas where basic clinical 
research has focused its attention but there are many problems associated with their local 
administration. For example, recombinant human growth factors are not cost effective, they 
have limited shelf life, and ineffectively delivered to target cells and in addition, to get 
efficient therapy, large doses are needed. The use of autologous platelets concentrates for 
tissue regeneration and wound healing has now become an alternative easy and cheap way 
to obtain high concentrations of these growth factors (34).  
The autologous blood collected from a patient just before surgery can be prepared as 
platelet concentrates, platelet-rich plasma (PRP) and platelet gel for the treatment the patient 
specifically needs (35). These forms are prepared by gradient density centrifugation 
techniques to obtain high (x5) concentration of platelets (36). This autologous concentration 
includes a large amount of growth factors, especially PRP is an easy and inexpensive 
technique to accelerate the wound healing (37).  
This quite new field is open for research, there are a lot of techniques still under 
development stage such as platelet gels can be obtained by adding thrombin to autologous 
platelet-rich plasma. The initiation of fibrin polymerization and the release of platelets 
factors and cytokines can be achieved by the specific activators such as thrombin, glass, 
freeze-thaw cycle to platelet-rich plasma depending on what is required during the surgery 
(35). 
In spite of the distinct features of platelet-rich plasma (PRP) and its use by different fields of 
medicine, no adverse reactions were documented until now(38, 39, 40, 41). 
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